Ranitidine
- Product NDC
- 45865-416
- 11-digit product format
- 458650416
- Labeler code
- 45865
- Product ID
- 45865-416_9ab204d5-bc25-a818-e053-2995a90ad0da
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranitidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Medsource Pharmaceuticals
- Application
- ANDA077824
- Marketing category
- ANDA
- Marketing start
- 2009-12-16
- Marketing end
- 0000-00-00
- Substance
- RANITIDINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 45865-416-60 | Ranitidine | 60 in 1 BOTTLE | TABLET | 60 | | 2 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 45865-416 | RANITIDINE TABLET [MEDSOURCE PHARMACEUTICALS] | 2 | Legacy NDC, 1 package rows | 20191228_1d733324-93c6-201c-e054-00144ff88e88.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 45865-416-60 | 45865041660 | 60 TABLET in 1 BOTTLE (45865-416-60) | 60 tablet | 2015-08-26 | 0000-00-00 | No | No | Current |